787 related articles for article (PubMed ID: 29705285)
1. Contribution of lymph node staging method and prognostic factors in malignant ovarian sex cord-stromal tumors: A world wide database analysis.
Wang J; Li J; Chen R; Lu X
Eur J Surg Oncol; 2018 Jul; 44(7):1054-1061. PubMed ID: 29705285
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of lymph node metastasis and prognostic significance of lymphadenectomy in apparent early-stage malignant ovarian sex cord-stromal tumors.
Nasioudis D; Kanninen TT; Holcomb K; Sisti G; Witkin SS
Gynecol Oncol; 2017 May; 145(2):243-247. PubMed ID: 28292524
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of lymphadenectomyin malignant ovarian sex cord stromal tumor: A retrospective cohort study and meta-analysis.
Cheng H; Peng J; Yang Z; Zhang G
Gynecol Oncol; 2018 Jan; 148(1):91-96. PubMed ID: 29107349
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women.
Zhang M; Cheung MK; Shin JY; Kapp DS; Husain A; Teng NN; Berek JS; Osann K; Chan JK
Gynecol Oncol; 2007 Feb; 104(2):396-400. PubMed ID: 17030354
[TBL] [Abstract][Full Text] [Related]
5. A novel nomogram based on LODDS to predict the prognosis of epithelial ovarian cancer.
Xu XL; Cheng H; Tang MS; Zhang HL; Wu RY; Yu Y; Li X; Wang XM; Mai J; Yang CL; Jiao L; Li ZL; Zhong ZM; Deng R; Li JD; Zhu XF
Oncotarget; 2017 Jan; 8(5):8120-8130. PubMed ID: 28042955
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--a multivariate analysis.
Chan JK; Zhang M; Kaleb V; Loizzi V; Benjamin J; Vasilev S; Osann K; Disaia PJ
Gynecol Oncol; 2005 Jan; 96(1):204-9. PubMed ID: 15589602
[TBL] [Abstract][Full Text] [Related]
7. Patterns of metastasis in sex cord-stromal tumors of the ovary: can routine staging lymphadenectomy be omitted?
Brown J; Sood AK; Deavers MT; Milojevic L; Gershenson DM
Gynecol Oncol; 2009 Apr; 113(1):86-90. PubMed ID: 19162310
[TBL] [Abstract][Full Text] [Related]
8. Log odds of positive lymph nodes is a superior prognostic indicator in stage III rectal cancer patients: A retrospective analysis of 17,632 patients in the SEER database.
Huang B; Chen C; Ni M; Mo S; Cai G; Cai S
Int J Surg; 2016 Aug; 32():24-30. PubMed ID: 27321382
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of lymph node ratio in stage IIIC epithelial ovarian cancer with node-positive in a SEER population-based study.
Zhou J; He ZY; Li FY; Sun JY; Lin HX; Wu SG; Chen QH
Oncotarget; 2016 Feb; 7(7):7952-9. PubMed ID: 26788911
[TBL] [Abstract][Full Text] [Related]
10. The individualized significance of lymphadenectomy across all age groups and histologies in malignant ovarian germ cell tumors.
Wang J; Chen R; Li J; Lu X
Arch Gynecol Obstet; 2020 Dec; 302(6):1441-1450. PubMed ID: 32888090
[TBL] [Abstract][Full Text] [Related]
11. [Predictive value of log odds of positive lymph nodes for the prognosis of patients with node-negative squamous cell carcinoma of the thoracic esophagus after radical esophagectomy].
Yang M; Zhang H; Huo X; Chen C; Yu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 May; 19(5):535-9. PubMed ID: 27215521
[TBL] [Abstract][Full Text] [Related]
12. Role of adjuvant chemotherapy in the management of non-granulosa cell ovarian sex cord-stromal tumors.
Nasioudis D; Orfanelli T; Frey MK; Chapman-Davis E; Caputo TA; Witkin SS; Holcomb K
J Gynecol Oncol; 2019 Mar; 30(2):e19. PubMed ID: 30740951
[TBL] [Abstract][Full Text] [Related]
13. Ovarian Sertoli-Leydig and granulosa cell tumor: comparison of epidemiology and survival outcomes.
Nasioudis D; Mastroyannis SA; F Haggerty A; M Ko E; Latif NA
Arch Gynecol Obstet; 2020 Aug; 302(2):481-486. PubMed ID: 32519016
[TBL] [Abstract][Full Text] [Related]
14. The Log Odds of Positive Lymph Nodes Stratifies and Predicts Survival of High-Risk Individuals Among Stage III Rectal Cancer Patients.
Lee CW; Wilkinson KH; Sheka AC; Leverson GE; Kennedy GD
Oncologist; 2016 Apr; 21(4):425-32. PubMed ID: 26975865
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Performance of Different Lymph Node Staging Systems in Patients With Small Bowel Neuroendocrine Tumors.
Jiang S; Zhao L; Xie C; Su H; Yan Y
Front Endocrinol (Lausanne); 2020; 11():402. PubMed ID: 32733379
[No Abstract] [Full Text] [Related]
16. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.
Goulvent T; Ray-Coquard I; Borel S; Haddad V; Devouassoux-Shisheboran M; Vacher-Lavenu MC; Pujade-Laurraine E; Savina A; Maillet D; Gillet G; Treilleux I; Rimokh R
Histopathology; 2016 Jan; 68(2):279-85. PubMed ID: 26033501
[TBL] [Abstract][Full Text] [Related]
17. Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology.
Bilici A; Inanc M; Ulas A; Akman T; Seker M; Babacan NA; Inal A; Bal O; Koral L; Sevinc A; Tufan G; Elkiran ET; Ustaalioglu BB; Yavuzsen T; Alkis N; Ozkan M; Gumus M
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6493-9. PubMed ID: 24377556
[TBL] [Abstract][Full Text] [Related]
18. Comparison of three lymph node classifications for survival prediction in distant metastatic gastric cancer.
Zhou R; Zhang J; Sun H; Liao Y; Liao W
Int J Surg; 2016 Nov; 35():165-171. PubMed ID: 27713088
[TBL] [Abstract][Full Text] [Related]
19. Evaluation on prognostic efficacy of lymph nodes ratio (LNR) and log odds of positive lymph nodes (LODDS) in complicated colon cancer: the first study in emergency surgery.
Occhionorelli S; Andreotti D; Vallese P; Morganti L; Lacavalla D; Forini E; Pascale G
World J Surg Oncol; 2018 Sep; 16(1):186. PubMed ID: 30213260
[TBL] [Abstract][Full Text] [Related]
20. Log odds of positive lymph nodes may predict survival benefit in patients with node-positive non-small cell lung cancer.
Deng W; Xu T; Wang Y; Xu Y; Yang P; Gomez D; Liao Z
Lung Cancer; 2018 Aug; 122():60-66. PubMed ID: 30032846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
